Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CMND
#5224
Clearmind Medicine Inc. Common Shares
1.1
3
-0.88%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.88%
Monthly Change
-56.70%
6 month change
+10.78%
Year Change
-8.13%
Previous Close
1.1
4
Open
1.1
3
Bid
Ask
Low
1.1
3
High
1.1
3
Volume
2
Markets
US Stock Market
Healthcare
CMND
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q4, 25
TTM
Cash from operating activities
—
—
—
Cash from investing activities
—
—
—
Cash from financing activities
—
—
—
Free cash flow
—
—
—
News
Clearmind Medicine: Aktie fällt trotz positiver Sicherheitsdaten aus klinischer Studie
Clearmind Medicine stock falls after Phase I/IIa trial safety update
Clearmind meldet positive Sicherheitsdaten in Studie zu Medikament gegen Alkoholkonsumstörung
Clearmind meldet positive Sicherheitsdaten für Medikamentenkandidaten gegen Alkoholkonsumstörung
Clearmind reports positive safety results in AUD drug trial
Clearmind reports positive safety data from AUD treatment trial
Clearmind-Aktie legt nach Deal für nasale Wirkstoffverabreichung deutlich zu
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal
Clearmind und Polyrizon kooperieren bei nasaler MEAI-Formulierung
Clearmind partners with Polyrizon to develop intranasal MEAI formulation
Polyrizon entwickelt nasale Formulierung für Clearminds Wirkstoffkandidaten MEAI
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug